Farmington Hills, MINCT06812988Now EnrollingIRB Ready

Type 1 Diabetes Clinical Trial in Farmington Hills, MI

Access cutting-edge type 1 diabetes treatment through this clinical trial at a research site in Farmington Hills. Study-provided care at no cost to qualified participants.

Sponsored by Sanofi

Quick Self-Assessment

See if you qualify for this Farmington Hills location

Preparing your pre-screening questions...

Expert Care in Farmington Hills

Access type 1 diabetes specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type 1 diabetes treatment provided free

Apply for This Farmington Hills Location

Check if you qualify for this type 1 diabetes clinical trial in Farmington Hills, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Farmington Hills

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Farmington Hills site if eligible
  4. 4Begin participation

About This Type 1 Diabetes Study in Farmington Hills

This is a randomized, placebo-controlled, parallel group, multicenter, double-blind Phase 2a, 2-arm study. The goal of this Phase 2a study is to assess safety and efficacy of SAR442970 in comparison to placebo to preserve β-cell function in participants with recently diagnosed type 1 diabetes (T1D) on insulin therapy. The study design comprises 2 parts: in Part A adult participants (18 to 35 years of age at screening) and in Part B adolescent and young adult participants (age range 12 to 21 ye

Sponsor: Sanofi

Who Can Participate

Inclusion Criteria

Participant must be 18 to 35 y.o. inclusive, at the time of signing the informed consent in order to be enrolled in Part A. Participant must be 12 to 21 y.o. inclusive, at the time of signing the informed consent in order to be enrolled in Part B. 2. Participants who meet the criteria of T1D according to American Diabetes Association (ADA 2024). 3. Initiated exogenous insulin replacement therapy not longer than 90 days prior to Screening visit at which random C-peptide will be assessed. 4. Receiving insulin hormone replacement therapy: 5. Participants must be positive for at least 1 of the following T1D autoantibodies confirmed by medical history and/or obtained at study Screening:
Glutamic acid decarboxylase (GAD-65)
Insulinoma Antigen-2 (IA-2)
Zinc-transporter 8 (ZnT8) or
Insulin (if obtained not later than 10 days after exogenous insulin therapy initiation) 6. Have random C-peptide levels ≥0.2 nmol/L determined at Screening.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Farmington Hills?

Yes, this clinical trial (NCT06812988) has an active research site in Farmington Hills, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type 1 Diabetes Treatment Options in Farmington Hills, MI

If you're searching for type 1 diabetes treatment options in Farmington Hills, MI, this clinical trial (NCT06812988) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Farmington Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type 1 diabetes clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Farmington Hills, MI

See all pulmonary embolism clinical trials recruiting in Farmington Hills — not just this study.

Browse Pulmonary Embolism Trials in Farmington Hills →

Browse More Trials by Condition

Pulmonary Embolism TrialsEssential Tremor TrialsType 1 Diabetes TrialsJuvenile Diabetes TrialsAll Conditions →

Ready to Join in Farmington Hills?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Farmington Hills, MI